Cook Pharmica LLC, a privately held contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, unveiled plans to expand its operations in Indiana creating up to 70 new jobs by 2020.

The company, which is a wholly-owned subsidiary of Bloomington, IN-based Cook Group, will invest $28 million to renovate and equip its facility in Bloomington, which is built on the grounds of the former RCA television assembly plant. With the addition of an additional drug product line, the company will fill drug product into syringes, vials—both liquid and lyophilized—and cartridges for Cook Pharmica’s clients. Readiness activities for the new line have already begun, with plans to have the new line operating in early 2017.
 
Cook Pharmica currently employs 575 associates, part of more than 13,000 Cook Group employees worldwide, and has already begun hiring for its growth.

“Cook was founded in Bloomington more than a half century ago, and we are thrilled to continue our company’s deep connection with the state of Indiana and the city of Bloomington,” said Tedd Green, president, Cook Pharmica. “Working with our partners at the Indiana Economic Development Corporation and the city of Bloomington, this expansion will continue Cook’s commitment to providing world-class biopharmaceutical manufacturing services to customers here and around the world.”
  
More than 1,700 life science companies like Cook Pharmacia operate across Indiana today, employing more than 56,000 Hoosiers and delivering a $59 billion economic impact in the state, according to BioCrossroads.